|
ZNF33A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01979544200981E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.29110000468557E-08 |
| Normal-vs-Stage2 |
7.52159999839463E-08 |
| Normal-vs-Stage3 |
2.58399968089407E-10 |
| Normal-vs-Stage4 |
1.09559999961206E-08 |
| Stage1-vs-Stage2 |
2.084800E-01 |
| Stage1-vs-Stage3 |
1.040420E-01 |
| Stage1-vs-Stage4 |
1.472410E-01 |
| Stage2-vs-Stage3 |
9.489600E-01 |
| Stage2-vs-Stage4 |
8.964800E-01 |
| Stage3-vs-Stage4 |
8.302400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.51509965368768E-11 |
| Normal-vs-AfricanAmerican |
3.158900E-03 |
| Normal-vs-Asian |
1.98319999999974E-06 |
| Caucasian-vs-AfricanAmerican |
3.083200E-01 |
| Caucasian-vs-Asian |
8.516600E-01 |
| AfricanAmerican-vs-Asian |
4.401000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.61679999891129E-09 |
| Normal-vs-Female |
9.87350201597792E-11 |
| Male-vs-Female |
8.134800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.09160000039132E-07 |
| Normal-vs-Age(41-60Yrs) |
4.6754000671001E-10 |
| Normal-vs-Age(61-80Yrs) |
1.70459979464965E-10 |
| Normal-vs-Age(81-100Yrs) |
1.601080E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.399600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.072000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.158200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.781400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.520000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.334200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.256000E-02 |
| Classical-VS-Follicular |
7.921300E-03 |
| Classical-VS-Other |
3.384000E-01 |
| Classical-VS-Normal |
6.69790001239789E-09 |
| Tall-VS-Follicular |
9.515600E-01 |
| Tall-VS-Other |
9.907800E-01 |
| Tall-VS-Normal |
4.6556000055098E-08 |
| Follicular-VS-Other |
9.680200E-01 |
| Follicular-VS-Normal |
4.58909998890533E-09 |
| Other-VS-Normal |
7.363100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97220018094413E-10 |
| Normal-vs-N1 |
2.14759999783709E-08 |
| N0-vs-N1 |
4.718400E-01 |
|
|
